“THE VALUE OF SYSTEMIC INFLAMMATORY BIOMARKERS IN ASSESSING SEVERITY IN PATIENTS WITH CEREBRAL INFARCTION”, YHCĐ, vol. 67, no. CĐ11-NCKH, July 2026, doi: 10.52163/yhc.v67iCD11.6035.